Skip to main content
Premium Trial:

Request an Annual Quote

Bionano Genomics Reduces Size of Proposed IPO

NEW YORK (GenomeWeb) – Bionano Genomics on Wednesday lowered the size of its proposed IPO, according to a filing with the US Securities and Exchange Commission.

The San Diego-based genomic research tools company plans to offer 2,450,000 units, each consisting of one share of common stock and one warrant to purchase a share of common stock, at a price of $6.00 to $7.00 per unit.

At the midpoint of the range, the company would raise about $16 million. In July BioNano had filed with the SEC to offer 5.5 million shares of stock for between $5 and $6 for a proposed maximum offering of about $38 million. And in its preliminary prospectus filed with the SEC in June the company said it was targeting $34.5 million.

The company's stock has been approved for listing on the Nasdaq under the symbol BNGO, and BioNano has applied for the listing of the units and the warrants on Nasdaq under the symbols BNGOU and BNGOW, respectively. The warrants and shares will trade together as units only during the first 30 days following the prospectus date, and thereafter will automatically separate and trade separately unless Roth Capital Partners, as the representative of the underwriters, determines that an earlier date is acceptable.

Bionano sells a DNA mapping system for structural variation detection called Saphyr that it launched commercially in 2017. The underlying optical mapping technology involves nanochannels that hold single DNA molecules. The company said it has an installed base of more than 90 systems, including both the Saphyr and its predecessor Irys.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.